General Info

OncoMed Pharmaceuticals, founded in 2004, is a biotechnology company that deals in providing cancer treatment for individuals. The company conducts cancer stem cell research programs and has established a library of antibodies for the treatment of solid tumors, such as pancreatic, breast, colorectal and lung cancer. It is a privately owned company that receives funds from a group of investors, including US Venture Partners, Latterell Venture Partners(LVP), The Vertical Group, Morgenthaler Ventures, Nomura Phase4 Ventures Limited, Delphi Ventures, Adams Street Partners, De Novo Ventures and Bay Partners. OncoMed Pharmaceuticals OncoMed has established various technologies for the detection, isolation and characterization of tumor initiating cells. The company has tested more than 150 antibodies.